FibroNest

Princeton, United States Founded: 2018 • Age: 8 yrs
AI tools for quantifying fibrosis and inflammation in medical images for drug development.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 3 Services tracked
Competitors 9 Brand Intelligence

About FibroNest

FibroNest is a company based in Princeton (United States) founded in 2018. It operates as a B2B. FibroNest offers products and services including FibroNest, OncoNest, and CardioNest. FibroNest operates in a competitive market with competitors including ArtiQ, Imbio, Predible, Sime Dx and Echoliv, among others.

  • Headquarter Princeton, United States
  • Sectors
    Technology
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Pharmanest Inc
Operational Areas
Technology → Artificial Intelligence & Machine Learning Unlock Sub-Sector Unlock Segment
Healthcare → Medical Devices & Diagnostics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of FibroNest

FibroNest offers a comprehensive portfolio of products and services, including FibroNest, OncoNest, and CardioNest.

Product name locked
Category locked
Primary

AI method for quantifying fibrosis in collagen-stained images.

Product name locked
Category locked
Locked

AI for oncology-related pathology image quantification.

Product name locked
Category locked
Locked

AI tool for cardiovascular disease pathology assessment.

Funding Insights of FibroNest

Premium access

Detailed funding history for FibroNest

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by FibroNest

Investments
Premium access

Investment portfolio details for FibroNest

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - FibroNest

Premium access

Detailed financials for FibroNest

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Fibronest Comparisons

FibroNest Primary company
Description
AI tools for quantifying fibrosis and inflammation in medica...
Location
Princeton, United States
Founded Year
2018
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for FibroNest

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of FibroNest

FibroNest operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ArtiQ, Imbio, Predible, Sime Dx and Echoliv, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
AI-powered software to optimize clinical trials and enhance diagnostic processes
Locked Locked Locked
Medical imaging analysis for respiratory clinical support is provided.
Locked Locked Locked
AI-based radiological analysis is provided for lung disease diagnosis.
Locked Locked Locked
Point-of-care digital diagnostics are developed and provided by Sime Dx.
Locked Locked Locked
AI-based tool for liver cancer diagnosis is provided to providers.
Premium access

Detailed competitors of FibroNest

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Fibronest

Premium access

Complete news archive for FibroNest

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about FibroNest

FibroNest was founded in 2018.

FibroNest is headquartered in Princeton, United States. It is registered at Princeton, New Jersey, United States.

PharmaNest provides advanced AI-driven digital pathology services, including FibroNest, which analyzes fibrosis phenotypes from stained slides for clinical and pre-clinical studies. It supports pharmaceutical drug development by offering high-resolution quantification compatible with various imaging systems. Based in Princeton, NJ, USA, it serves researchers and companies in fibrosis-related fields, validated across multiple conditions like liver and lung diseases.

FibroNest's top competitors include Predible, ArtiQ and Sime Dx.

FibroNest offers FibroNest, OncoNest, and CardioNest.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available